Basics MIRUM PHARMACEUTICALS, INC. IPO Date: July 12, 2019 Sector: Healthcare Industry: Biotech Market Cap: $3.82B Activated in VL: True Average Daily Range Avg Daily Range: $0.60 | 2.56% Avg Daily Range (30 D): $1.25 | 2.00% Avg Daily Range (90 D): $0.90 | 1.69% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .66M Avg Daily Volume (90 D): .43M Trade Size Avg Trade Size (Sh.): 59 Avg Trade Size (Sh.) (30 D): 52 Avg Trade Size (Sh.) (90 D): 46 Institutional Trades Total Inst.Trades: 1,686 Avg Inst. Trade: $2.16M Avg Inst. Trade (30 D): $3.53M Avg Inst. Trade (90 D): $3.08M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.62M Avg Closing Trade (30 D): $5.54M Avg Closing Trade (90 D): $4.01M Avg Closing Volume: 79.65K     News Jun 18, 2024 @ 3:14 PM Mirum (MIRM) Soars on Interim Data From Liver Dise... Source: Zacks Equity Research Jun 18, 2024 @ 9:46 AM Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Furth... Source: Zacks Equity Research Jun 7, 2024 @ 3:30 PM Why Is Mirum Pharmaceuticals (MIRM) Down 3.4% Sinc... Source: Zacks Equity Research May 28, 2024 @ 2:02 PM Mirum's (MIRM) Livmarli Aids Sales but Overdepende... Source: Zacks Equity Research May 9, 2024 @ 3:46 PM Mirum's (MIRM) Q1 Earnings & Revenues Fall Shy of ... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.21 $-.12 $-.3 Diluted EPS $-1.21 $-.12 $-.3 Revenue $ 429.16M $ 127.79M $ 111.59M Gross Profit $ $ $ Net Income / Loss $ -58.56M $ -5.86M $ -14.68M Operating Income / Loss $ -57.08M $ -4.99M $ -15.18M Cost of Revenue $ $ $ Net Cash Flow $ -6.88M $ 14.13M $ -11.74M PE Ratio